See also this year's filing and all EDGAR filings for this company.
PDF Report 0001502152_2019_GlobeStar_Therapeutics_Corp.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001502152')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001502152, GlobeStar Therapeutics Corp
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 111,807 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 1,294 |
3 | remainder_Assets | 11,644 |
4 | LiabilitiesCurrent | 995,476 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 207 |
8 | SellingGeneralAndAdministrativeExpense | 351,735 |
9 | ResearchAndDevelopmentExpense | 0 |
10 | remainder_Expenses | 103,490 |
11 | remainder_Revenues | 6,421 |
12 | remainder_NetIncome | -367,730 |
13 | remainder_ComprehensiveNetIncome | 1,941 |
yvar | yval | |
---|---|---|
0 | Assets | 124,745 |
1 | Liabilities | 995,476 |
2 | Expenses | 455,432 |
3 | Revenues | 6,421 |
4 | StockholdersEquity | -870,731 |
5 | NetIncome | -816,741 |
6 | ComprehensiveNetIncome | -815,770 |
7 | BaseVar | 975,872 |
8 | EconomicCapitalRatio | -4.13 |